Research in context
RELAPSE

The efficacy of a single 300-mg dose of tafenoquine co-administered with chloroquine for the radical cure of 
This is the first clinical study to evaluate the efficacy and safety of a single 300-mg dose of tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of 
This study does not support co-administration of a single 300-mg dose tafenoquine with dihydroartemisinin–piperaquine for the radical cure of The emergence of chloroquine resistanceThe INSPECTOR study (Indonesian Study Proving Efficacy of Combination Therapy on Relapse) is the first study to evaluate co-administration of tafenoquine with dihydroartemisinin–piperaquine for the radical cure of 